ConductScience.org, home

Paper4201225

Pseudomonas aeruginosa vaccine in cancer patients.

Young LS and 2 others. Ann Intern Med, 1973. Cited by 139 papers, by iCite.

Cite this record

ConductScience Library. Pseudomonas aeruginosa vaccine in cancer patients. Papers, record 4201225. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/4201225

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pseudomonas aeruginosa vaccine in cancer patients.
PubMed
Journal
Ann Intern Med
PubMed
Year
1973
PubMed
Publication types
Clinical Trial, Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
139
iCite
Relative citation ratio, by iCite
4.58
iCite
Revised in PubMed
2019-06-19
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Young LSL S
2Meyer RDR D
3Armstrong DD

Source PubMed

Download CSV of authors

Topics12

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Bacterial VaccinesMajor topic
NeoplasmsMajor topic
Pseudomonas InfectionsMajor topic
Pseudomonas aeruginosaMajor topic
VaccinationMajor topic
Adult
Antibodies, Bacterial
Humans
Immunization Schedule
Leukopenia
Prospective Studies
Sepsis

Source PubMed

Download CSV of topics

Cited by37

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 139 citations.

PMIDTitleJournalYearIn PapersSource
40821801Fc-modification of anti-PcrV gene-encoded antibodies modulates complement-mediated killing of Pseudomonas aeruginosa.Front Immunol2025https://conductscience.org/library/papers/40821801PubMed
40076637Pseudomonas aeruginosa Vaccine Development: Lessons, Challenges, and Future Innovations.Int J Mol Sci2025https://conductscience.org/library/papers/40076637PubMed
37459522Immunization with lytic polysaccharide monooxygenase CbpD induces protective immunity against Pseudomonas aeruginosa pneumonia.Proc Natl Acad Sci U S A2023https://conductscience.org/library/papers/37459522PubMed
37432116Hit 'em Where It Hurts: Gram-Negative Bacterial Lipopolysaccharide as a Vaccine Target.Microbiol Mol Biol Rev2023https://conductscience.org/library/papers/37432116PubMed
35891262Pseudomonas aeruginosa: Recent Advances in Vaccine Development.Vaccines (Basel)2022https://conductscience.org/library/papers/35891262PubMed
34066555Strategies to Tackle Antimicrobial Resistance: The Example of Escherichia coli and Pseudomonas aeruginosa.Int J Mol Sci2021https://conductscience.org/library/papers/34066555PubMed
33291484Understanding Pseudomonas aeruginosa-Host Interactions: The Ongoing Quest for an Efficacious Vaccine.Cells2020https://conductscience.org/library/papers/33291484PubMed
29547971Potential targets for next generation antimicrobial glycoconjugate vaccines.FEMS Microbiol Rev2018https://conductscience.org/library/papers/29547971PubMed
24575895Vaccines for Pseudomonas aeruginosa: a long and winding road.Expert Rev Vaccines2014https://conductscience.org/library/papers/24575895PubMed
21941090Recent developments for Pseudomonas vaccines.Hum Vaccin2011https://conductscience.org/library/papers/21941090PubMed
11035726Preparation and preclinical evaluation of a novel liposomal complete-core lipopolysaccharide vaccine.Infect Immun2000https://conductscience.org/library/papers/11035726PubMed
8132318Specificity and function of murine monoclonal antibodies and immunization-induced human polyclonal antibodies to lipopolysaccharide subtypes of Pseudomonas aeruginosa serogroup 06.Infect Immun1994https://conductscience.org/library/papers/8132318PubMed
7520416Immunogenic and antigenic properties of a heptavalent high-molecular-weight O-polysaccharide vaccine derived from Pseudomonas aeruginosa.Infect Immun1994https://conductscience.org/library/papers/7520416PubMed
6799548Safety and immunogenicity of high molecular weight polysaccharide vaccine from immunotype 1 Pseudomonas aeruginosa.J Clin Invest1982https://conductscience.org/library/papers/6799548PubMed
6793519Polysaccharide of the slime glycolipoprotein of Pseudomonas aeruginosa.Infect Immun1981https://conductscience.org/library/papers/6793519PubMed
6551339Passive protection against Pseudomonas aeruginosa infection in an experimental leukopenic mouse model.Infect Immun1983https://conductscience.org/library/papers/6551339PubMed
6430805Immunochemical characterization of high-molecular-weight polysaccharide from Fisher immunotype 3 Pseudomonas aeruginosa.Infect Immun1984https://conductscience.org/library/papers/6430805PubMed
6429046Preparation and characterization of a nontoxic polysaccharide-protein conjugate that induces active immunity and passively protective antibody against Pseudomonas aeruginosa immunotype 1 in mice.Infect Immun1984https://conductscience.org/library/papers/6429046PubMed
6425224Role of lipopolysaccharide in virulence of Pseudomonas aeruginosa.Infect Immun1984https://conductscience.org/library/papers/6425224PubMed
6404816Simple model for the study of Pseudomonas aeruginosa infections in leukopenic mice.Infect Immun1983https://conductscience.org/library/papers/6404816PubMed

See all 37 cited byDownload CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/4201225

GET https://conductscience.org/api/papers/v1/4201225/cited_by?page=2